Preliminary Ampligen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Preliminary Ampligen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Preliminary Ampligen Today - Breaking & Trending Today

AIM ImmunoTech Enrolls and Doses First Subject in Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions

Published: July 10, 2023

Preliminary Ampligen data demonstrates potential to be an effective treatment option for post-COVID conditions Enrollment expected to be completed in Q4 2023 OCALA, Fla., July 10, 2023 ...

Source: marketscreener.com

Related Topics:

United StatesThomask EquelsImmunotech IncInitiative SolveCompany On TwitterPreliminary AmpligenExecutive Officer ThomasFatigue ScoreSix Minute Walk TestCognitive Function ScoreSleep DisturbancePrivate Securities Litigation Reform Act